Unknown

Dataset Information

0

Remarkable Phenytoin Sensitivity in 4 Children with SCN8A-related Epilepsy: A Molecular Neuropharmacological Approach.


ABSTRACT: Mutations in SCN8A are associated with epilepsy and intellectual disability. SCN8A encodes for sodium channel Nav1.6, which is located in the brain. Gain-of-function missense mutations in SCN8A are thought to lead to increased firing of excitatory neurons containing Nav1.6, and therefore to lead to increased seizure susceptibility. We hypothesized that sodium channel blockers could have a beneficial effect in patients with SCN8A-related epilepsy by blocking the overactive Nav1.6 and thereby counteracting the effect of the mutation. Herein, we describe 4 patients with a missense SCN8A mutation and epilepsy who all show a remarkably good response on high doses of phenytoin and loss of seizure control when phenytoin medication was reduced, while side effects were relatively mild. In 2 patients, repeated withdrawal of phenytoin led to the reoccurrence of seizures. Based on the findings in these patients and the underlying molecular mechanism we consider treatment with (high-dose) phenytoin as a possible treatment option in patients with difficult-to-control seizures due to an SCN8A mutation.

SUBMITTER: Boerma RS 

PROVIDER: S-EPMC4720675 | biostudies-literature | 2016 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Remarkable Phenytoin Sensitivity in 4 Children with SCN8A-related Epilepsy: A Molecular Neuropharmacological Approach.

Boerma Ragna S RS   Braun Kees P KP   van den Broek Marcel P H MP   van Berkestijn Frederique M C FM   Swinkels Marielle E ME   Hagebeuk Eveline O EO   Lindhout Dick D   van Kempen Marjan M   Boon Maartje M   Nicolai Joost J   de Kovel Carolien G CG   Brilstra Eva H EH   Koeleman Bobby P C BP  

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 20160101 1


Mutations in SCN8A are associated with epilepsy and intellectual disability. SCN8A encodes for sodium channel Nav1.6, which is located in the brain. Gain-of-function missense mutations in SCN8A are thought to lead to increased firing of excitatory neurons containing Nav1.6, and therefore to lead to increased seizure susceptibility. We hypothesized that sodium channel blockers could have a beneficial effect in patients with SCN8A-related epilepsy by blocking the overactive Nav1.6 and thereby coun  ...[more]

Similar Datasets

| S-EPMC6689675 | biostudies-literature
| S-EPMC7780473 | biostudies-literature
| S-EPMC4688066 | biostudies-literature
| S-EPMC10401093 | biostudies-literature
| S-EPMC10441468 | biostudies-literature
| S-EPMC10792783 | biostudies-literature
| S-EPMC3090066 | biostudies-literature
| S-EPMC3339501 | biostudies-other
| S-EPMC10387795 | biostudies-literature
| S-EPMC7221122 | biostudies-literature